Ever Supreme Bio Technology Co., Ltd (TPEX: 6712)

Ever Supreme Bio Technology Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 18, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	13,956	14,338	15,025	13,013	9,856	9,043
Market Cap Growth	-0.23%	-4.57%	15.46%	32.03%	8.99%	59.89%
Enterprise Value	13,324	13,324	13,889	11,764	9,488	8,387
Last Close Price	173.00	172.46	175.17	148.22	123.93	113.71
PE Ratio	55.00	26.58	74.86	35.21	-	-
PS Ratio	16.55	18.91	23.94	29.65	139.61	835.88
PB Ratio	8.82	7.78	8.38	6.86	12.62	10.69
P/TBV Ratio	9.55	7.82	8.44	6.90	12.79	10.81
P/FCF Ratio	33.91	34.47	47.55	97.32	-	-
P/OCF Ratio	35.99	34.00	47.07	95.90	-	-
EV/Sales Ratio	15.77	17.57	22.13	26.81	134.40	775.20
EV/EBITDA Ratio	32.58	37.25	45.20	83.16	-	-
EV/EBIT Ratio	35.18	39.45	48.94	101.24	-	-
EV/FCF Ratio	32.37	32.04	43.95	87.99	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.04
Debt / EBITDA Ratio	0.01	0.02	0.06	0.23	-	-
Debt / FCF Ratio	0.01	0.01	0.06	0.26	-	-
Asset Turnover	0.44	0.37	0.31	0.30	0.08	0.01
Inventory Turnover	2.75	3.48	2.94	4.19	3.52	-
Quick Ratio	2.90	6.20	8.28	14.58	10.73	20.73
Current Ratio	3.31	6.57	8.89	15.20	11.87	21.68
Return on Equity (ROE)	15.29%	29.68%	10.88%	27.60%	-13.13%	-10.60%
Return on Assets (ROA)	12.40%	10.43%	8.88%	5.04%	-11.10%	-9.12%
Return on Capital (ROIC)	14.18%	11.54%	9.48%	5.27%	-11.51%	-9.34%
Earnings Yield	1.82%	3.76%	1.34%	2.84%	-1.08%	-1.04%
FCF Yield	2.95%	2.90%	2.10%	1.03%	-2.00%	-1.40%
Dividend Yield	3.15%	3.16%	0.94%	2.54%	-	-
Payout Ratio	173.02%	25.27%	154.19%	-	-	-
Buyback Yield / Dilution	1.91%	0.84%	-0.15%	-11.01%	-0.09%	-6.37%
Total Shareholder Return	5.06%	4.01%	0.80%	-8.47%	-0.09%	-6.37%

Source: S&P Capital IQ. Standard template. Financial Sources.